ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 270 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $360,403 | -79.4% | 19,150 | -71.7% | 0.01% | -86.6% |
| Q1 2021 | $1,746,000 | +205.8% | 67,674 | +533.5% | 0.07% | +204.5% |
| Q4 2020 | $571,000 | +5.2% | 10,682 | -18.8% | 0.02% | -38.9% |
| Q3 2020 | $543,000 | -2.5% | 13,156 | +14.5% | 0.04% | +5.9% |
| Q2 2020 | $557,000 | – | 11,494 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 474,741 | $7,557,877 | 7.35% |
| Finepoint Capital LP | 1,176,830 | $18,735 | 6.06% |
| Baker Brothers Advisors | 41,923,486 | $667,421,897 | 4.01% |
| Palo Alto Investors LP | 2,376,369 | $37,831,794 | 3.23% |
| EcoR1 Capital, LLC | 5,991,479 | $95,384,346 | 2.90% |
| Birchview Capital, LP | 249,400 | $3,970 | 2.80% |
| Bain Capital Life Sciences Investors, LLC | 701,402 | $11,166 | 1.25% |
| Ikarian Capital, LLC | 325,000 | $5,174,001 | 1.25% |
| RTW INVESTMENTS, LP | 3,670,938 | $58,441,333 | 1.19% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,048,750 | $16,696,100 | 1.03% |